VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 763 filers reported holding VANECK VECTORS ETF TR in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,442,058 | +261.4% | 127,910 | +304.4% | 0.84% | +208.1% |
| Q2 2023 | $952,379 | +233.4% | 31,630 | +258.2% | 0.27% | +227.7% |
| Q1 2023 | $285,651 | -94.0% | 8,830 | -94.9% | 0.08% | -85.3% |
| Q2 2022 | $4,752,000 | +35.6% | 173,530 | +89.9% | 0.56% | +41.4% |
| Q1 2022 | $3,504,000 | +378.0% | 91,375 | +299.5% | 0.40% | +329.0% |
| Q4 2021 | $733,000 | -90.9% | 22,875 | -91.7% | 0.09% | -90.9% |
| Q3 2021 | $8,095,000 | +7.5% | 274,682 | +24.0% | 1.02% | +30.3% |
| Q2 2021 | $7,530,000 | +151.7% | 221,587 | +140.8% | 0.79% | +106.3% |
| Q1 2021 | $2,992,000 | -86.0% | 92,037 | -84.5% | 0.38% | -87.2% |
| Q4 2020 | $21,325,000 | -21.4% | 592,051 | -14.6% | 2.98% | +31.2% |
| Q3 2020 | $27,147,000 | +108.4% | 693,230 | +95.2% | 2.27% | -10.3% |
| Q2 2020 | $13,028,000 | +133.7% | 355,185 | +46.8% | 2.53% | -44.1% |
| Q1 2020 | $5,574,000 | -50.2% | 241,907 | -36.7% | 4.53% | -21.3% |
| Q4 2019 | $11,194,000 | +57.2% | 382,319 | +43.4% | 5.75% | +408.6% |
| Q3 2019 | $7,119,000 | -60.4% | 266,543 | -62.1% | 1.13% | -39.4% |
| Q2 2019 | $17,986,000 | +58.3% | 703,662 | +38.8% | 1.87% | +5.4% |
| Q1 2019 | $11,363,000 | -23.9% | 506,837 | -28.4% | 1.77% | +17.4% |
| Q4 2018 | $14,937,000 | +60.4% | 708,250 | +40.9% | 1.51% | +89.1% |
| Q3 2018 | $9,310,000 | +104.8% | 502,700 | +146.8% | 0.80% | +195.6% |
| Q2 2018 | $4,545,000 | +158.5% | 203,715 | +154.6% | 0.27% | +145.5% |
| Q1 2018 | $1,758,000 | -59.3% | 80,000 | -57.0% | 0.11% | -38.5% |
| Q4 2017 | $4,323,000 | -43.0% | 186,015 | -43.7% | 0.18% | -41.3% |
| Q3 2017 | $7,579,000 | -42.0% | 330,108 | -44.2% | 0.30% | -56.3% |
| Q2 2017 | $13,059,000 | +47.5% | 591,419 | +52.3% | 0.70% | +28.3% |
| Q1 2017 | $8,856,000 | -65.8% | 388,232 | -68.7% | 0.54% | -61.3% |
| Q4 2016 | $25,931,000 | -13.1% | 1,239,523 | +9.7% | 1.41% | +6.7% |
| Q3 2016 | $29,853,000 | -22.3% | 1,129,509 | -18.5% | 1.32% | -22.7% |
| Q2 2016 | $38,425,000 | – | 1,386,653 | – | 1.71% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |